Literature DB >> 17880357

Ischaemic complications of Glypressin in liver disease: a case series.

Fergal Donnellan1, Garret Cullen, John E Hegarty, P Aiden McCormick.   

Abstract

AIM: To report three cases of extensive skin necrosis in cirrhotic patients treated with the vasoconstrictor agent terlipressin (Glypressin).
METHODS: We identified three patients who developed skin necrosis and determined any factors, which put them at an increased risk of doing so.
RESULTS: Two patients were obese and developed extensive abdominal wall skin necrosis. The third patient had lower limb chronic venous insufficiency and developed extensive necrosis of both lower limbs.
CONCLUSIONS: With increasing clinical use of terlipressin and an increasing incidence of obesity and non-alcoholic fatty liver disease-related cirrhosis, the incidence of these serious complications is likely to rise. Earlier recognition and treatment may lead to improved outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880357      PMCID: PMC2048543          DOI: 10.1111/j.1365-2125.2007.02921.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Microvascular changes in venous disease: an update.

Authors:  A Bollinger; A J Leu; U Hoffmann; U K Franzeck
Journal:  Angiology       Date:  1997-01       Impact factor: 3.619

Review 2.  Microvascular changes in chronic venous insufficiency--a review.

Authors:  A J Leu; H J Leu; U K Franzeck; A Bollinger
Journal:  Cardiovasc Surg       Date:  1995-06

3.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

4.  Terlipressin-related acute myocardial infarction: a case report and literature review.

Authors:  Min-Yi Lee; Chin-Sheng Chu; Kun-Tai Lee; Hsiang-Chun Lee; Ho-Ming Su; Kai-Hung Cheng; Sheng-Hsiung Sheu; Wen-Ter Lai
Journal:  Kaohsiung J Med Sci       Date:  2004-12       Impact factor: 2.744

Review 5.  Review article: pharmacological treatment of hepatorenal syndrome.

Authors:  P Ginès; A Torre; C Terra; M Guevara
Journal:  Aliment Pharmacol Ther       Date:  2004-09       Impact factor: 8.171

6.  Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.

Authors:  F Vaccaro; A Giorgi; O Riggio; A De Santis; A Laviano; F Rossi-Fanelli
Journal:  Dig Liver Dis       Date:  2003-07       Impact factor: 4.088

7.  [Ischemia of the cecum caused by glycylpressin].

Authors:  M G Willems; J Schoenemann; C Rey; H Schäfer; K D Lindecken
Journal:  Leber Magen Darm       Date:  1985-07

8.  Ischaemic colitis in a patient treated with glypressin for bleeding oesophageal varices.

Authors:  W Schmitt; E Wagner-Thiessen; G Lux
Journal:  Hepatogastroenterology       Date:  1987-06
  8 in total
  6 in total

1.  Safety and Efficacy of Terlipressin in Pediatric Distributive Shock: A Retrospective Analysis in 20 Children.

Authors:  Jörg Michel; Michael Hofbeck; Gina Spiller; Hanna Renk; Matthias Kumpf; Felix Neunhoeffer
Journal:  Paediatr Drugs       Date:  2017-02       Impact factor: 3.022

2.  A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease.

Authors:  Heon Ju Lee; Myung Jin Oh
Journal:  Clin Mol Hepatol       Date:  2013-06-27

3.  Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.

Authors:  Hae Rim Kim; Young Sun Lee; Hyung Joon Yim; Hyun Joo Lee; Ja Young Ryu; Hyun Jung Lee; Eileen L Yoon; Sun Jae Lee; Jong Jin Hyun; Sung Woo Jung; Ja Seol Koo; Rok Sun Choung; Sang Woo Lee; Jai Hyun Choi
Journal:  Clin Mol Hepatol       Date:  2013-12-28

4.  Terlipressin-induced ischemic skin necrosis: a rare association.

Authors:  Banu Demet Ozel Coskun; Ahmet Karaman; Hasan Gorkem; Irfan Buğday; Orhan Kursad Poyrazoğlu; Fatma Senel
Journal:  Am J Case Rep       Date:  2014-10-31

5.  Embolia cutis medicamentosa: an unusual adverse reaction to terlipressin.

Authors:  Polychronis Gatos-Gatopoulos; Stephanos Kostantoudakis; Ioannis G Panayiotides; George D Dimitriadis; Konstantinos Triantafyllou
Journal:  Ann Gastroenterol       Date:  2017-05-11

6.  Terlipressin-induced ischaemic skin necrosis.

Authors:  Anand V Kulkarni; Pramod Kumar; Nagaraj P Rao; Nageshwar Reddy
Journal:  BMJ Case Rep       Date:  2020-01-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.